Real-world experience with ocrelizumab in primary Progressive multiple sclerosis: Insights from the MSOCR-P cohort, a MSBase Registry sub-study
H. Butzkueven,T. Spelman,S. Ozakbas,G. Laureys,L. Van Hijfte,R. Alroughani,J. L. Sanchez Menoyo,V. Van Pesch,T. Kalincik,J. Lechner-Scott,A. Van der Walt,F. Grand'Maison,C. Boz,K. Buzzard,O. Skibina,M. Terzi,J. I. Rojas,M. Barnett,Y. Fragoso,E. Cartechini,E. Pucci,B. Willekens,E. Butler,Y. Blanco,N. Grigoriadis,T. Al-Harbi,P. Dirks,C. Liu,E. Muros-Le Rouzic MULTIPLE SCLEROSIS JOURNAL（2022）
AI 理解论文
溯源树
样例
